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Aerob høy intensitets intervall trening er en effektiv behandling for pasienter 
med kronisk obstruktiv lungesykdom 
Aerob høy intensitets intervallsykling ved 85-95% av peak hjertefrekvens forbedrer 
peak oksygen opptak og maksimal yteevne hos pasienter med kronisk obstruktiv 
lunge sykdom. Ett bens sykling gir større økning i helkropps peak oksygenopptak 
sammenlignet med to bens sykling. Hos ett bens gruppen gjør en og en fot hver for 
seg en større jobb enn når begge føttene jobber samtidig, uten at ventilasjonen er 
forskjellig. Derfor gjør ett bens sykling det mulig for pasientene å jobbe med en 
høyere muskel spesifik intensitet sammelignet med to bens sykling som resulterer i en 
betydelig bedre treningsrespons. 
Aerob høy intensitets ett bens sykling ved 85-95% av peak hjertefrekvens i normoksi 
og hyperoksi forbedrer peak oksygenopptak og maksimal yteevne hos pasienter med 
kronisk obstruktiv lungesykdom. Å puste inn 100% oksygen under trening øker ikke 
peak oksygenopptak ytterligere sammenlignet med å puste romluft. Heller ikke ved 
akutt måling av oksygenopptaket er det forskjell mellom å puste i hyperoksi og 
normoksi, selv om den arterielle oksygen metningen i blodet er betydelig høyere i 
hyperoksi før og etter treningsperioden, noe som indikerer en oksygen forbruks 
begrensning i de perifere musklene. 
Aerob høy intensitets intervalltrening i hyperoksi ved 85-95% av peak hjertefrekvens 
øker peak oksygenopptak, maksimal yteevne, arbeidsøkonomi og livskvaliteten hos 
pasienter med kronisk obstruktiv lungesykdom som har oksygen metningsfall 
(SpO2<88%) ved maksimal aktivitet. En oksygen forsynings begrensning er synlig 
hos pasientene med kronisk obstruktiv lungesykdom gjennom et betydelig høyere 
peak oksygenopptak og en bedre yteevne når de puster ekstra oksygen sammenlignet 
med romluft under testing før og etter treningsperioden. På den andre siden ser vi 
ingen akutt forskjell i peak oksygenopptak mellom hyperoksi og normoksi hos 
pasientene med koronar hjerte sykdom, noe som indikerer en oksygen 
forbruksbegrensning hos disse pasientene.
Bakgrunnen for å gjennomføre studiene var å finne trenings metoder som gjorde at 
pasienter med kronisk obstruktiv lunge sykdom som i utgangspunktet er ventilatorisk 
begrensede, kunne holde en aerob høy intensitet over en periode der både hjertet og 
de perifere musklene fikk optimal stimulering. I tillegg ønsket vi å undersøke i 
hvilken grad pasientene er begrenset av oksygen tilførselen til muslkaturen eller av 
oksygen forbruket i muskelen når det gjelder peak oksygenopptak. Studiene er 
gjennomført som kontrollerte treningsintervensjoner med testing av utholdenhet før 
og etter 8 uker med høy intensitet intervall trening. 
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4Summary
Aerobic high intensity interval cycling at 85-95% of peak heart rate improves peak oxygen 
uptake (VO2peak) and performance in severe chronic obstructive pulmonary disease patients 
(COPD). One leg cycling demonstrates greater improvement in whole body VO2peak than two 
legs cycling. The work load performed leg by leg in the one leg group is greater than when 
both legs are working together, however the ventilatory load is not different. Thereby the one 
leg cycling allows the patients to train at a higher muscle-specific intensity compared to 
whole body exercise, resulting in a significantly greater training response. 
Aerobic high intensity one leg interval cycling at 85-95% of peak heart rate in normoxia and 
hyperoxia improves VO2peak and performance in patients with severe COPD. However, 
breathing 100% oxygen during training does not improve VO2peak above the level attained by 
breathing ambient air. Neither does acute hyperoxia increase VO2peak compared to normoxia 
despite a higher arterial oxygen saturation during testing both before and after the training 
period, which indicates an oxygen demand limitation to VO2peak in the peripheral muscles in 
both stages. 
Hyperoxic aerobic high intensity interval training at 85-95% of peak heart rate increases 
VO2peak, performance, work economy and quality of life in severe COPD patients with 
hypoxemia (SpO2< 88%) at peak exercise. Oxygen supply limitation is demonstrated in the 
COPD group by a significant improved VO2peak and performance in acute hyperoxia 
compared to normoxia during testing both before and after the training period. On the 
contrary, no acute difference between hyperoxia and normoxia suggests an oxygen demand 
limitation in the coronary artery disease patients (CAD).   
51 Introduction 
Chronic obstructive pulmonary disease (COPD) is one of the most common causes of death in 
most countries, and the only common cause of death in the Unites States that has increased 
over the last 40 years, in sharp contrast to the reduction in cardiovascular and infectious 
diseases [1]. COPD was the sixth leading cause of death in 1990 and is estimated to become 
the third leading cause of death worldwide by 2020, mostly related to the expanded epidemic 
of smoking and the increasingly older population [2, 3]. The disease causes increase of 
chronic disability and is predicted to become the fifth most common cause of chronic 
disability worldwide by 2020 [3, 4]. COPD is also one of the most common reasons for sick 
leave from work, placing an enormous and increasing economic burden on the society [3, 5]. 
The World Health Organisation (WHO) have estimated that currently 80 million people have 
moderate to severe COPD and that more than 3 million people died from the disease in 2005, 
approximately 5 % of all deaths globally [2]. The prevalence of COPD is related to age and 
smoking but is found to be underestimated due to unawareness of the disease in subjects 
suffering from COPD. In addition, a lack of correct diagnostics in those seeking medical 
advice is frequent [6]. It is demonstrated that hospitalized patients with COPD has a higher 
hospitalization prevalence and in-hospital mortality from co-morbidities such as hypertension, 
diabetes, coronary artery disease, heart failure, pulmonary infections, cancer, and pulmonary 
vascular disease than the COPD itself [7, 8]. Chronic lung disease has a significant impact on 
cardiovascular function due to an increased right ventricular afterload caused by increased 
pulmonary vascular resistance resulting from structural changes in the pulmonary circulation, 
as well as hypoxic pulmonary vasoconstriction [9].   
Patients suffering from COPD are physiologically limited by the inability to engage in the 
usual activities of daily living due to reduced pulmonary function and poor exercise capacity 
[10, 11]. Exercise intolerance progresses relentlessly as the disease advances and can lead to 
virtual immobility, social isolation and eventually early death [12].. Evidence based 
guidelines for pulmonary rehabilitation by the American association of cardiovascular and 
pulmonary rehabilitation in conjunction with the American College of Chest physicians, list 
exercise training as a mandatory component of pulmonary rehabilitation for patients with 
COPD [13]. 
A strong correlation between endurance capacity expressed as maximal oxygen uptake 
(VO2max) and the risk for mortality has been demonstrated in both healthy subjects and those 
6with cardiovascular disease [14], while improvements in aerobic capacity reduces the 
mortality risk [15]. Exercise capacity is found to be a predictor of mortality in COPD 
independent of the FEV1 and that VO2peak is an excellent predictor of long-term survival [16]. 
VO2max is defined as the highest rate at which oxygen can be taken up and utilized by the 
body during exercise with large muscle groups [17, 18]. An increase in VO2max by only 3.5 ml 
oxygen pr. kg bodyweight resulted in 12 % improved survival [14]. Since most COPD 
patients show extremely poor exercise performance [19, 20], and the exercise capacity 
declines over time [21], these findings highlights the importance of exercise among COPD 
patients to increase their quality of life and to prevent an early death [22]. The pulmonary 
damages related to COPD are not reversible even by cessation of smoking [23], and thereby 
the single most important factor to treat the disease and increase life expectancy is to increase 
the patient’s aerobic endurance capacity [13]. 
1.1 Aerobic endurance
Aerobic endurance depends on the ability to perform large-muscle, whole body exercise at 
moderate to high intensities for expended periods of time and is determined primarily by 
VO2max and to a lesser degree of the lactate threshold and work economy [17]. The 
importance of a superior aerobic endurance capacity is best exposed in elite athletes 
competing in different sports with continued exercise [24], whereas the significance of being 
physical fit in non athletes and patients is often neglected. The importance of an increased 
aerobic endurance capacity is highlighted by the fact that it might prevent an early death in 
those with genuine low exercise capacity and increase quality of life in healthy people [14]. 
VO2max is considered to be the present ”gold standard” for measurement of cardiovascular 
fitness and is a useful parameter for determining aerobic endurance also for patients with 
COPD [25].  
1.2 Maximal oxygen uptake 
VO2max is the single most important physiological measurement of aerobic endurance [26] and 
relates to the highest rate at which oxygen can be transported from ambient air to the working 
skeletal muscles and utilized during severe exercise. It depends on oxygen transport from the 
atmosphere to the muscle mitochondria and reflects the combined functional capacities of the 
cardiac output, the oxygen carrying capacity of the blood and the oxidative capacity of the 
active skeletal muscle [17, 18, 27]. Oxygen uptake (VO2) is the product of cardiac output 
7(CO) and the arteriovenous oxygen difference ([(a – v) O2 difference]) and is given by the 
Fick equation: 
VO2 = CO · (a – v) O2 difference        (1.1) 
Cardiac output is a product of the heart rate and stroke volume of the heart. The variation in 
oxygen delivery to locomotor muscles is solely a function of the size of  the stroke volume, as 
maximal heart rate and arterial oxygen content both are unaffected by training [28]. 
Endurance trained individuals with a high VO2max have both a superior capacity to deliver and 
utilize oxygen than untrained individuals [24]. VO2max varies among individuals due to factors 
such as body size, muscle mass, genetics, age, gender and conditioning status [17, 29]. When 
comparing elite endurance athletes and ordinary subjects, total hemoglobin and arterial 
oxygen saturation remains equal. Muscle oxygen extraction percentage is higher, however 
insufficient to account alone for the elite level of performance. The most important difference 
is found in maximal cardiac output with values twice as high documented in the elite athlete 
[30, 31]. VO2max  is task specific and has been found to be 10-20 % lower in biking compared 
to walking/running [32]. VO2 increases linearly with increasing power output and reaches a 
plateau with further increases in work rate at VO2max. However in many subjects, as the work 
rate increases, termination of work is demonstrated before this plateau is reached [31]. In such 
situations where the VO2max criteria are not fulfilled, the term peak oxygen uptake (VO2peak) is 
more commonly used which is the highest level of oxygen that can be taken up and utilized 
by the body during exercise under a given condition (e.g. reduced muscle mass, in untrained 
individuals or disease). In patients with cardiovascular and pulmonary disease it might be 
angina pain or ventilation that limits the work intensity and the term VO2peak is thereby used 
[33, 34].
1.3 Limitations to VO2max 
A plateau of VO2max is evidence of maximal metabolic oxidative phosphorylation that can 
reach maximum ATP generation and not a limitation per se of oxygen limitation of VO2 [31]. 
This means that every step of the oxygen cascade from the air into the mitochondria is a 
potential deterrent for VO2max. If the oxidative phosphorylation is limited by the availability 
of mitochondrial oxygen, which is determined by how fast the oxygen can be delivered to the 
muscle cell, a supply limitation is present. If the oxygen availability in the mitochondria 
outreaches the utilization by the oxidative phosphorylation, the system is demand limited 
8[31]. Wagner states that in ambient air at sea level, maximal oxygen uptake in athletic 
individuals is primarily set by oxygen transport limitation (i.e. cardiac output), whereas in 
unfit subjects, it is set by metabolic limitations [31]. This is either by a conductance/diffusion 
limitation [35, 36] or a limitation in the mitochondria to reach a maximum respiratory rate 
[37-40]. These claims are supported by the literature demonstrating that unfit individuals may 
be exposed to reduced or increased oxygen content without any changes in VO2 [41]. The 
opposite is however the case in fit subjects and athletes [42-44]. A 2-3 times muscular 
overcapacity of the aerobic energy production when the whole body is employed was 
demonstrated by Saltin et al. [45], an evidence of supply limitation of VO2max in healthy 
subjects during whole body work. This demonstrates that VO2max is not an absolute concept, it 
is acutely changeable by altering parts of the metabolic pathway [31]. By calculating the 
contribution of the individual steps of the respiratory cascade, DiPrampero [46] concluded 
that for healthy humans exercising in normoxia, about 75 % of VO2max is set by central 
oxygen transport and 25 % by the periphery.
1.4 Aging, inactivity and aerobic endurance 
When evaluating COPD responses, age related physiological changes have to be taken into 
account as most of the individuals who are afflicted by the disease are elderly people [47, 48]. 
COPD often results in a progressive decline in exercise capacity, reductions in muscle mass 
and strength because of the vicious cycle of physical inactivity and deconditioning [1, 11, 49]. 
These effects are thought to be superimposed on the decline in VO2max, lean body mass and 
muscle strength expected with an inactive lifestyle followed by aging. However regular 
aerobic exercise seems to prevent and restore the muscle metabolic and vascular losses in 
aging people [50-52] and in elderly patients with COPD [53]. It has been demonstrated that 
elderly people respond to high intensity aerobic interval training (85-95 % of maximal heart 
rate) and increase their VO2peak in the same manner as young people [50, 54]. A decline in 
VO2max of § 10% per decade after 30 years of age has been observed in studies of healthy 
individuals [55, 56]. It has been found that the decline in VO2max is proportional to a 
decreased cardiac output, peak heart rate and peak stroke volume in older subjects [57]. It is 
debated whether this decrease in exercise capacity is due to the ageing process or the 
inactivity followed by aging [58]. Studies have demonstrated that it is a result of 
deconditioning [59] and that endurance training prevents and restores VO2max  [54, 60-62]. In 
physical active subjects VO2max remains higher at all ages compared to inactive subjects [58]. 
9As demonstrated in the classic “Dallas bed rest study”, 3 weeks of complete inactivity had the 
same detrimental effect on VO2max as 30 years of aging [63].  
1.5 COPD; the disease 
COPD has been defined in the GOLD (global initiative for chronic obstructive lung disease) 
guidelines as a disease state characterized by airflow limitation that is not fully reversible 
[64]. The airflow limitation is usually both progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles or gases [65]. Although COPD is a 
disease primarily affecting the lungs, it also produces significant systemic consequences [8]. 
COPD is a joint designation of Emphysema and Chronic bronchitis. Emphysema is defined as 
a condition of the lungs characterized by abnormal, permanent enlargement of air spaces 
distal to the terminal bronchiole accompanied by destruction of their walls and without 
obvious fibrosis [66]. Chronic bronchitis is defined by increased airway resistance and 
productive cough lasting > 3 months for at least 2 consecutive years. It results from mucus 
hypersecretion which leads to microscopic and macroscopic changes in the airway structure 
such as mucus production, epithelial changes, airway inflammation, smooth muscle cell 
hypertrophy and submucosal bronchial gland enlargement [67]. Most COPD patients have 
both emphysema and chronic bronchitis [68]. Even though there are incidences of COPD 
from Į1-antitrypsin deficiency [69], increased risk due to dusty environments [70] and 
childhood respiratory illness, which may render people susceptible to tobacco-induced lung 
damage [71], COPD is almost always caused by excessive cigarette smoking over many years 
[3, 8, 72].
The number and sizes of holes in the alveolar walls are increased in COPD and alveolar 
attachments to small airways are disrupted. In combination with an ongoing chronic 
inflammation in the airways, this leads to a remodelling and narrowing of the small airways 
which diminish the ability of the airways to remain open during expiration and hinders 
ventilation by trapping air in the bronchioles and alveoli, resulting in an increased dead space. 
In COPD patients, the residual lung volume increases due to a slow forced emptying of the 
lungs accompanied by a decreased expiratory flow rate. The airflow limitation is slowly 
progressive and irreversible [73-75].
COPD is diagnosed by Spirometry which measures the volume of air that is forcibly exhaled 
from the point of maximal inspiration, forced vital capacity (FVC), and the volume of air 
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exhaled during the first second, forced expiratory volume in one second (FEV1). The ratio 
between these two measurements (FEV1/FVC) is calculated, and the degree of lung function 
abnormality decided. A post-bronchodilator FEV1/FVC < 0.7 confirms the presence of an 
airflow limitation that is not fully reversible. The severity of the disease has been divided into 
four stages which is a post-bronchodilator FEV1/FVC ratio of < 0.70, and a FEV1 % 
predicted; mild (FEV1 >80), moderate (50 < FEV1 < 80), severe (30 < FEV1 < 50) and very 
severe (FEV1 < 30, or FEV1 < 50 plus chronic respiratory failure). In addition, patients who 
smoke or have exposure to pollutants, have cough, sputum or dyspnoea are classified “at risk” 
with a FEV1/FVC ratio of > 0.70 and a FEV1 % predicted >80 [8]. The FEV1/FVC ratio 
declines with age, however the fixed FEV1/FVC ratio of < 0.70 as a threshold for defining 
COPD is found reliable also in older subjects (> 65 years) [76]. It has been demonstrated that 
in patients with COPD, FEV1 is the single best predictor for mortality [77].  
1.6 COPD and physical activity 
COPD is primarily a pulmonary disease which limits the patients’ ability to breathe during 
graded exercise. An increased dead space/tidal volume ratio induces a ventilatory inefficiency 
during exercise serving as one of the main causes of decreased exercise capacity in patients 
with COPD [78]. Ventilation fails to keep pace with oxygen consumption as minute 
ventilation does not rise as much as carbon dioxide production and oxygen uptake, causing 
the arterial partial pressure of carbon dioxide to rise and oxygen to decrease [79]. During 
physical activity, increased ventilatory demands and decreased maximum ventilation leads to 
a decreased breathing reserve which consequently results in dyspnoea [80]. Patients with 
COPD have a progressively reduced exercise capacity [1, 11, 81] and the fundamental 
symptoms that limits exercise in most patients are dyspnoea and/or fatigue which may result 
from ventilatory constraints, pulmonary gas exchange abnormalities, peripheral muscle 
dysfunction, cardiac dysfunction or any combination of the above [9, 10, 20, 40, 82-84].
There is a growing realization that COPD is a multi- organ system disease which affects the 
exercise capacity by the ability to transport oxygen to the working muscles and to consume 
oxygen in the mitochondria [85, 86]. Patients with COPD experience a substantial morbidity 
from secondary impairments such as peripheral muscle, cardiac, nutritional and psychosocial 
dysfunction. Pulmonary rehabilitation should thereby focus on prevention and restoration of 
these parameters to the highest possible level of independent function which is crucial for 
increasing the patient’s daily living and their quality of life [10, 87]. Physical training 
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increases capillarization [88] and mitochondrial development [89], and are maintained in 
proportion to the aerobic endurance of the whole organism [90], thereby an exercise training 
program of the peripheral muscles is recommended as a mandatory component of pulmonary 
rehabilitation for patients with COPD [13, 65, 91, 92]. 
An ongoing debate among researchers is whether COPD patients have a peripheral skeletal 
muscle dysfunction which might contribute to the exercise intolerance, or if similar 
physiologic adaptations to aerobic endurance training such as structural changes in the 
peripheral muscles and the cardiovascular system occur as in healthy subjects. Casaburi [48]
claims that in COPD, the metabolic alterations in the muscles are evidence of a skeletal 
muscle dysfunction due to marked differences in lactate release, venous carbon dioxide 
accumulation and respiration in the leg at submaximal exercise compared to healthy 
individuals. On the contrary, Richardson et al. [40, 93, 94] claims that COPD patients have a 
skeletal muscle metabolic reserve, however they state that the skeletal muscle performance is 
reduced due to the muscle fibre type composition and muscle disuse. Documentation of 
changes in the locomotor skeletal muscles that constitute myopathy has been detected in 
COPD patients [81, 83, 95-98]. Deconditioning might be a possible co-mechanism in the 
peripheral muscle abnormalities as it has been demonstrated that skeletal muscle strength is 
correlated with exercise tolerance and that patients with COPD commonly possess peripheral 
muscle weakness [20] and excessive perception of leg fatigue during exercise [19]. Muscle 
wasting and reduced strength is a consequence of the inactive lifestyle in COPD patients [49, 
84, 99] and gain in muscle mass and strength has been associated with better exercise 
tolerance and survival [100, 101].
In healthy elderly subjects as well, improvement in peripheral muscle mass and strength is 
associated with a better exercise capacity [102]. Healthy elderly individuals gradually 
experience a decreased fraction fast-twitch glycolytic type II- and increased slow-twitch 
oxygenated type I muscle fibres [103]. This is in contrast to COPD patients who have a 
decreased fraction of oxidative type I fibres compared to type II fibres [81, 94, 97] and 
thereby low levels of mitochondria, oxidative enzymes and decreased capillary density 
followed by a low capacity for oxygen consumption which is a significant contributor to work 
capacity limitation [49, 83, 94, 97, 98, 104-107]. Increased muscle strength and endurance 
improves muscular recruitment and oxidative capacity in the exercising muscles of COPD 
patients [100, 106, 108, 109]. In addition to a low proportion type I muscle fibres, a reduction 
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of oxidative enzyme activity is present within the type II fibres [81]. The skeletal muscle 
abnormalities reflected by the reduced mitochondrial (aerobic) potential and compromised 
oxidative phosphorylation results in an exaggerated dependence on high energy phosphate 
transfer and anaerobic glycolysis leading to an early onset of lactate accumulation [82, 83, 
110, 111]. The early lactate accumulation in COPD may stimulate increased ventilation and 
hasten the onset of ventilation limitation. Reduced lactate concentration for a given exercise 
work load that accompanies exercise training decreases carbon dioxide output and thereby 
reduces the ventilation requirement allowing the patients  to tolerate a given exercise level for 
a longer period [112]. Improved aerobic endurance and decreased levels of lactate 
concentration and ventilation at a given exercise level after training reflects the link between 
skeletal muscle function and exercise capacity in COPD [113]. Because of the ventilatory, 
muscular or symptom limitations at peak exercise, the heart rate is not maximally challenged 
in patients with COPD. A reduced stroke volume at all exercise intensities is also a consistent 
finding in COPD, primarily caused by reductions in right ventricular output due to lung 
hyperinflation, increased pulmonary vascular resistance and reduced venous return as a result 
of increased intra-thoracic pressure which in turn reduces left ventricular filling [9, 114].
It is widely accepted that exercise should be a basic part of any pulmonary rehabilitation 
program as it is the most important treatment in COPD [75]. The importance of exercise 
training in pulmonary rehabilitation is doubtless as it improves both exercise tolerance and 
health related quality of life [75, 115]. Inspiratory muscle training alone or in addition to 
exercise training has not been prooven superior compared to exercise training alone when 
concerning exercise capacity, performance or health related quality of life [116, 117]. 
Endurance training appears to be the best form of training compared to resistance training and 
ventilatory muscle training [118]. 
1.7 Training effects
Aerobic high intensity interval training has been demonstrated to increase VO2max by 7 % in 
healthy active young male students [119] whereas the same training intervention has resulted 
in an 15 % increase in healthy elderly subjects over 65 years [54]. Aerobic high intensity 
interval training in patients with intermittent claudication, coronary artery disease and heart 
failure have demonstrated increases in VO2peak by as much as 16-46 % [120-122]. The 
increase in VO2peak/max in these studies was dependent on training modality, with significant 
greater increase after aerobic high intensity interval training compared to their respective 
13
control groups performing moderate intensity continuous training. In the field of COPD, the 
majority of training interventions use performance measured by watt, walking distance, time 
to exhaustion etc. as the main outcome to describe training effects. These methods are rather 
diffuse. Diffuse are also recommendations concerning aerobic exercise prescription in COPD 
patients which aims at exercise for 20-60 minutes 3-5 days a week at an intensity 
corresponding to 55-95% of maximal heart rate [123]. This is a very general exercise advice 
with no clear recommendation.  
In COPD studies measuring increase in VO2peak, a vide range of  training interventions is 
used. A resemblance in these studies is adjustment of training intensity to be able to sustain 
the requiered duration, aiming at the highest possible intensity tolerated related to dyspnoea or 
based on the Borg scale [87, 113, 124-130]. The most frequent increase in VO2peak is about 4-
8 % after 20-30 minutes contnous work regulated by a work lolad as high as possible. 
However, most patients were unable to achieve the work load defined in their respecctive 
studies (> 70% peak work load) [87, 113, 124, 125, 127]. Some studies actually demonstrate 
no increase in VO2peak after 10-12 weeks of training. These training interventions consisting 
of 40-45 min continous moderate-low intensity training (50-60% peak work load), high 
intensity short interval (30 sek) training (100% of peak work load) [131, 132], and high 
intensity (90% of peak work load) short intervals (1 min) [133]. One study lasted 10 weeks, 
with 5 trainings pr week for 80 minutes, consisting of 2 min low intensity (>50% peak work 
load) interval cycling for 20 minutes, and 60 minutes of other exercise activities, without any 
increase in VO2peak [129]. Some studies demonstrate greater increases in VO2peak >10%. 
Studies consisting of  >30 moderate-high intensity (60-70% of peak work load) continous 
training sessions has found increase in VO2peak by 10-17% [126, 133, 134], whereas greater 
increase ( ࡱ 20%)  has been demonstrated after 15 min one leg high intensity training (50% of 
two legs peak work load) [128].
1.8 Training intensity 
Several studies have demonstrated that training intensity is the most important factor 
concerning improvements in aerobic endurance and VO2max in both healthy subjects and 
patients [119-122, 135-138]. Intensities up to 90% of VO2max in healthy subjects [119, 139] 
and 90% of VO2peak in patients [120-122] has been demonstrated to be more beneficial than 
lower intensities. Also in COPD patients the physiological effects of training are 
demonstrated to be greater in those who are able to train at higher intensities compared to 
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lower intensities [108, 113, 130, 140-143]. Many low and moderate intensity studies 
demonstrate nonsignificant increases or even decreases in VO2peak and performance after 
training [144-148]. It has also been demonstrated that oxidative enzymes of peripheral 
muscles increases only after high intensity training and not after low intensity training [149]. 
Exercise capacity is severely compromised in COPD because of ventilatory limitation [78, 
150] and due to the increased work of breathing and muscular symptoms during exercise, 
high intensity training (>70% of peak work load) are hardly tolerated for longer periods of 
time [108, 109, 113]. As common training intensities in COPD is moderate (<70% of peak 
work load) to be able to sustain trainig duration ( ࡱ 30 min), heart rate will not be desirable 
challenged and the muscle oxygen diffusing capacity might not reach its potential maximal 
value during exercise [9]. Muscle biopsies have demonstrated increases in the levels of 
aerobic enzymes and capillary density of leg muscles after high intensity training in COPD 
patients [107, 109].
1.9 Interval training 
Interval training consists of intermitted work alternating with active rest. In athletes and 
healthy older subjects, interval training increase VO2max, work load and lactate thresholds to a 
greater extent than continuous low to moderate intensity training [151-153]. Aerobic high 
intensity interval training performed by 4x4 minutes at 85-95% of maximal heart rate 
intermittet by 3 minutes at 60-70% of maximal heart rate has demonstrated significantly 
improved VO2max and peak work load compared to continues training at lower intensities (< 
70-75 % of maximal heart rate) in healthy young subjects [119, 154, 155] and sedentary 
elderly adults [156].
In COPD patients, ventilation constrain exercise tolerance due to rapidly developing 
hyperinflation and dyspnoea, thereby increased intensity is hardly sustained [78].
As the working periods is intermittent with resting periods, high intensity is better tolerated in 
COPD patients during interval training [75, 99, 157] and they are able to perform a greater 
amount of work than during continuous exercise [158, 159]. Thereby interval training elicits 
great training responses at a reduced ventilatory level by a delayed onset of dynamic 
hyperinflation and dyspnoea which allows a greater opportunity for exercise progression [38, 
78, 150]. However, as several studies on healthy and diseased people have demonstrated great 
increases in VO2max/peak by performing 4 x 4 minutes intervals at 85-95% of peak heart rate 
[54, 119-122], interval periods used in most COPD studies last from 20 seconds to 1 minute at 
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90-100% of peak work load [131-133, 159]. In these studies, an increased performance is 
demonstrated by increased quality of life, work load and/or walking distance, but without 
significant increase in VO2peak. However, as the intensity in therse studies is near maximal 
work loads, an increase in VO2peak is not expected. One study of COPD patients performing 3 
minute intervals 2 times pr week for 16 weeks at >80% of peak work load demonstrated 
increased VO2peak, but the increase was only about 5% [126].
1.10 Reduced muscle mass 
Isolated small muscle mass exercise and one leg cycling has demonstrated greater muscle 
mass specific power output and stimulus than whole body exercise in COPD patients, 
potentially leading to a greater training response [40, 94, 128, 160]. In healthy people, leg 
blood flow and leg VO2peak increases during one leg cycling compared to two legs cycling 
where an increased vascular resistance causes a reduced blood flow to the working muscles 
and reduces oxygen delivery/diffusion [161, 162]. The respiratory muscles demand about 14-
16% of cardiac output during heavy exercise [163], whereas during reduced muscle mass 
exercise, central components are less taxed resulting in increased vascular conductance and 
blood flow, allowing a greater level of skeletal muscle perfusion to be achieved [164-166]. As 
a greater proportion of the blood is directed to the isolated area, VO2peak in the isolated 
quadriceps muscle group is demonstrated to be 2-3 times higher than measured in the same 
muscle group during whole-body work [45, 167].
For individuals with impaired lung function, the added demand for rapid gas exchange in 
whole-body work with increased intensity might result in exercise cessation. This is due to the 
increased cost of breathing as demonstrated by loaded respiratory muscle reducing VO2max,
performance and leg blood flow, as a consequence of blood redistribution away from the 
locomotor muscles and vasoconstriction compromising perfusion [38, 163, 166]. Increased 
inspiratory muscle work may contribute to dyspnoea and exercise limitation even before the 
ventilatory ceiling is attained [157, 168]. During small muscle mass exercise like one leg 
cycling, sufficient oxygen rich blood is allowed to supply the working muscles without any 
competition from other muscles which in turn facilitate the ventilatory work and increases the 
blood flow [38, 99]. This increases the ability for ventilatory limited patients to sustain the 
high intensity training and thereby recruit their maximal muscle conductance. This strategy 
has been found to increase VO2peak by ࡱ 20% in COPD patients performing 15 minutes one by 
one leg cycling [128].
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1.11 Training and testing in hyperoxia 
Oxygen diffusion from air to blood is a product of the partial pressure difference of oxygen 
between alveolar air and capillary blood and depends on alveolar ventilation and capillary 
perfusion, the alveolar and capillary surface areas, haemoglobin content and membrane 
thickness [169]. Oxygen supply to the skeletal muscle is a function of the arterial oxygen 
content and muscle blood flow [170]. Hyperoxia is defined as an inspiration of a gas mixture 
with an oxygen content exceeding ambient air and has at maximal exercise demonstrated 
increased arterial oxygen saturation [37, 171, 172] and performance in endurance athletes [43, 
173, 174] as well as in healthy and untrained subjects [37, 42, 175].
In COPD patients, ventilation/perfusion fails to keep pace with oxygen consumption causing 
an increased dead space [18] and reduced arterial oxygen saturation [79, 176]. Oxygen acts a 
dilator in the pulmonary circulation [177] whereas it might be a vasoconstrictor in vascular 
beds in both healthy [172] and COPD patients [178]. However, a higher oxygen content in the 
arterial blood by breathing supplemental oxygen overbalances the vasoconstrictor effect of 
oxygen [179] on the microvasculature and might thereby improve exercise tolerance by 
improving peripheral oxygen saturation and delivery [39, 110, 180]. Hyperoxia during aerobic 
exercise training in COPD patients has been demonstrated to improve exercise tolerance, 
performance and respiratory muscle function [181] due to relief of the ventilatory work and 
dyspnoea by a decreased stimulation of the chemoreceptors in the carotid and aortic bodies 
[182], relief of pulmonary vasoconstriction and decreased ventilatory rates [183] resulting in a 
reduced ventilatory requirement for a given exercise [39, 182, 184-188]. Thereby the 
respiratory or cardiovascular system is required to do less work, or to work more efficiently at 
a given work load [176]. Long term hyperoxia may induce pulmonary vasodilatation and 
improve right heart function [189].  
The increased oxygen pressure increases arterial oxygen saturation in the blood and thereby 
systemic oxygen delivery which increases the “driving force” for oxygen diffusion into the 
muscle [129, 190]. Together with increased blood flow in hyperoxia [39], this might in turn 
increase limb muscle oxygen utilization and enable the exercising muscles to perform more 
external work, which has been demonstrated to increase the physical performance because it 
allows for higher training intensity [127] and might elicit shear stress. Hyperoxia has also 
been found to improve skeletal muscle electrical activity during dynamic exercise [191].  
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Even though hyperoxia increases intracellular partial pressure of oxygen and thereby VO2peak
[39, 127], this relationship is not constant as it has been demonstrated an increased 
performance in hyperoxia compared to normoxia without any difference in VO2peak [188], 
indicating a borderline in terms of supply limitation [192, 193].   
Acute hyperoxia during peak exercise might reveal the contribution of factors limiting 
VO2peak. Increased VO2peak in acute hyperoxia compared to normoxia indicate a limitation by 
the cardiovascular system to supply the working muscles with oxygen in normoxia, whereas 
no difference in VO2peak between hyperoxia and normoxia indicate a demand limitation in the 
muscles to consume oxygen. Due to special required equipment, not many studies have 
measured hyperoxic VO2peak. However, acute hyperoxia during whole body cycling and one 
legged knee-extension in patients with COPD has demonstrated a metabolic reserve capacity 
during whole body work by an increased performance in hyperoxia compared to normoxia 
[40]. A subsequent study documented that the greater work capacity of the lower limbs in 
hyperoxia was accompanied by increases in oxygen delivery and oxygen uptake in the leg 
[39], which indicate that the metabolic capacity of the lower limb muscles to consume oxygen 
was not exhausted in COPD patients in normoxia. A few studies both on healthy subjects and 
COPD patients have demonstrated that inspiration of oxygen enriched air during whole body 
and small muscle group exercise did not increase performance or VO2peak despite increased 
tissue oxygen diffusion driving pressure [129, 194, 195]. This suggests a peripheral limitation 
to VO2peak which may relate to the reaching of a ceiling for maximal mitochondrial oxygen 
turnover.
1.12 Work economy 
Work economy is defined as oxygen cost at a standardized workload and refers to the ratio 
between work output and energy input. It establishes the relationship between maximal 
steady-state VO2 and work up to the lactate threshold level. Endurance capacity is dependent 
upon work economy and lactate threshold in addition to VO2peak , whereas work economy 
influences the work rate at VO2peak [17]. This might result in increased peak work load 
without any increase in VO2peak due to the reduced oxygen cost to perform the same work pre 
and post training. Reduced mechanical efficiency has been demonstrated in COPD patients, 
and is defined as the precentage of total energy expended that contributes to external work, 
with the remainder lost at heat [196]. This seems to be related to muscle fibre type 
composition with reduced muscular oxidative enzyme activity, metabolism and muscle 
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capillarization in addition to physical inactivity [11, 94, 98, 197, 198]. It has been established 
that high intensity endurance training improves submaximal exercise performance in COPD 
patients [199]. Maximal strength training improves work economy due to an elevated rate of 
force development and increased maximal strength demonstrated by working at a relative 
lower percent related to 1RM at the same work load pre and post training [200, 201]. As 
previously discussed there is a growing reliance upon type II muscle fibres as exercise 
intensity increases in COPD. The type II muscle fibres have been proposed leading to less 
efficient muscular work. Fibre type changes and subsequent fibre type recruitment may 
explain the decreased mechanical efficiency in these patients [94].
1.13 Quality of life 
COPD has a negative impact on health related quality of life [75], but improves as a result of 
increased exercise capacity after rehabilitation [100, 126, 199, 202-205]. Improvements in 
quality of life seem to be related to an improvement in work economy and an increased 
VO2peak accompanied by aerobic high intensity training [120, 199, 206]. Thereby comparable 
changes in health related quality of life and exercise capacity in COPD patients following 
aerobic interval training has been identified [131, 132]. 
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2 Objective, aims an hypotheses of the studies 
The main focus of the present thesis was to explore new and improved aspects of endurance 
training for patients with chronic obstructive pulmonary disease, and to investigate whether 
peak oxygen consumption are primarily limited by the reduced pulmonary function and 
thereby the capacity to transport oxygen to the working muscles or by the muscles capacity to 
utilize the available oxygen. 
Paper I: Aerobic high intensity one and two legs interval cycling in Chronic Obstructive 
Pulmonary Disease; the sum of the parts is greater than the whole
The aim of the study was to to assess the impact of aerobic high intensity interval training in 
COPD patients and reveal whether this training modality performed using individual leg 
cycling could produce a higher whole body training response than two legs cycling.
It was hypothesised that; 
Aerobic high intensity one leg interval cycling will maximally challenge the 
peripheral muscles without gaining a ventilatory limitation, and thereby result in a 
significantly greater whole body VO2peak training response than aerobic high intensity 
two legs interval cycling.
Paper II: Aerobic high intensity one leg interval cycling improves peak oxygen uptake in 
Chronic Obstructive Pulmonary Disease patients; no additional effect from hyperoxia 
The aim of the study was to address whether hyperoxia during high intensity aerobic interval 
one leg cycling in COPD patients show additional training effects on VO2peak compared to 
ambient air, in addition to exploring the acute exercise limitations. 
It was hypothesised that; 
1. COPD patients performing aerobic high intensity one leg interval cycling in hyperoxia 
will increase VO2peak and performance more than those training in normoxia due to the 
increased driving force of oxygen into the mitochondria.  
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2. If a metabolic reserve capacity exists in the muscles to consume oxygen pre and post 
training, it will be revealed by increased VO2peak in acute hyperoxia compared to 
normoxia as more oxygen is available in the vascular bed.     
Paper III: Hyperoxic interval training in chronic obstructive pulmonary disease patients 
with oxygen desaturation at peak exercise
The aim of the study was to address if hyperoxia during whole body training in COPD 
patients with oxygen desaturation at peak exercise (SpO2 < 88%) increase VO2peak and 
performance more than in normoxia. This might be due to an increased oxygen 
delivery/diffusion into the muscles which allow the patients to maintain the high intensity 
metabolic muscular work. 
It was hypothesised that
1. Hyperoxia during aerobic high intensity interval training in COPD patients with 
oxygen desaturation at peak exercise allows the patients to sustain the preferable high 
training intensity and increase the driving force of oxygen into the working muscles 
which will result in a great improvement in VO2peak and performance pre to post 
training.
2. Acute hyperoxia at pre and post test will increase VO2peak and performance compared 
to normoxia due to the oxygen supply limitation in normoxia.
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3 Methods
3.1 Subjects
37 COPD patients and 8 coronary artery disease (CAD) patients was included in the present 
thesis (Table 1). Inclusion and exclusion criteria are described in detail in the papers. 
19 COPD patients completed the study described in paper I, 12 in the one leg group and 7 in 
the two legs group. In study II described in paper II, 7 and 5 COPD patients completed the 
one leg training intervention in hyperoxia and normoxia respectively. In study III described in 
paper III, CAD patients who did not oxygen desaturate at peak exercise were used as controls 
to compare the hyperoxic stimuli during training and acutely during testing in subjects with a 
different disease and thereby physiological condition. 
Table 1 Overview of the subjects included in the thesis and the inclusion criteria in each 
study.
 Number of patients Inclusion criteria 
 Intervention COPD CAD 
Paper 1 2 GOLD stage additional criteria Angina pectoris class 
I 12 COPD 7 COPD III - - 
II 7 COPD 5 COPD III - - 
III 6 COPD 8 CAD III exercise SpO2 < 88 % I-III 
COPD; chronic obstructive pulmonary disease, CAD; coronary artery disease, GOLD stage 
III; FEV1 between 30 - 50% and FEV1/ FVC < 70% of predicted value, SpO2; arterial oxygen 
saturation, Angina pectoris classification see Braunwald et al. [207]. 
3.2 Testing procedures  
The pulmonary function tests were performed at the hospital by research nurses. All physical 
exercise capacity tests were performed in the exercise physiology laboratory at the hospital 
area, organized and accomplished by two exercise physiologists and supervised by a medical 
doctor.
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3.2.1 Spirometry
Flow volume Spirometry measurements were performed at room temperature (20 to 22°C) 
with the Master Screen pneumo Spirometer, version 4.1 (Jaeger GmbH & Co KG). The 
spirometer was calibrated daily, and the better of two post bronchodilator measurements with 
< 5% variation was recorded. The tests were performed at approximately the same time of 
day, and there were no change in medication during the studies.  
3.2.2 Work economy 
In study III, work economy at a work load corresponding to 20 and 40 watt in the COPD and 
the CAD group respectively during treadmill walking was measured. The COPD patients 
performed the test at 20 watts due to their severe condition. Oxygen uptake in each subject 
was divided by 20 and 40 watts in the COPD and the CAD group respectively so that they 
were comparable. To define the walking speed which corresponded to 20 watts and 40 watts 
on the treadmill the following equation was used: 
> @ 6.3)sin(  Tgm
workloadV
b
         (2.1) 
V = velocity [km ·h-1]
Work load = 20/40 Watt [Nm · s-1]
g = gravitational constant [9.8 m · s-2]
mb = body mass [kg] 
ș = treadmill inclination [deg] 
3.6 = converting velocity expressed [m · s-1] into [km ·h-1]
Oxygen uptake was determined by measuring 5 minutes continuous respiration, and defined 
as the mean oxygen uptake at the three latest 10 sec measurements.  
3.2.3 Peak oxygen uptake 
VO2peak was determined by increasing the work load until the subjects reached exhaustion. 
Continuous respiratory measurements were carried out and the mean of the three highest 10 
seconds continuous respiratory measurements determined VO2peak. In study II and III the 
Sensormedics V-max spectra 229 analyzer (Sensormedics Corp, California, USA) was used in 
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respiratory measurements due to the hyperoxia testing, and in study I Cortex Metamax II 
portable metabolic test system (Cortex  Biophysic GmbH, Lepzig, Germany) was used to 
obtain respiratory measurements.   
           (a)       (b) 
Fig. 1 Incremental peak exercise testing performed by two legs cycling while breathing 
supplemental oxygen (a) and ambient air (b). 
In study I and II the subjects cycled on an ergometer bike (Electronic Ergomedic 839E, 
Monark Exercise AB, Sweden). Work load was gradually increased until the subjects reached 
exhaustion. In study III VO2 was measured during treadmill walking (Technogym runrace, 
Italy) and the work load was increased either by speed or inclination until the subjects reached 
exhaustion. To decide VO2peak the mean of the three highest 10 second continuous oxygen 
uptake measurements were used.  
In study III the subjects tested work economy and VO2peak both in normoxia and in hyperoxia 
(65% oxygen which were the highest amount of oxygen the analyzer could measure). The two 
tests were performed in a random order separated with at least a 24 hour rest period.
3.3 Training procedures
In all studies the training intervention performed were aerobic high intensity interval training 
either by two legs cycling (I), one leg cycling (I and II) or treadmill walking (III). The 
subjects trained in normoxia (I and II) and in hyperoxia (II and III) in a total of 24 training 
sessions. The hyperoxia training was performed during one leg cycling (II) and treadmill 
walking (III) by breathing oxygen through a face mask with a three way valve connected to a 
200 litres plastic bag, constantly refilled with 100% oxygen from a gas reservoir tank.  
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After 5-10 minutes cycling or walking at the intensity comfortable for warm up, patients 
performed 4 x 4 minutes of aerobic high intensity intervals at 85-95% of the individual 
patients’ peak heart rate, corresponding to 80-90% of VO2peak. 3 minutes of active rest periods 
(60-70% of VO2peak) were used in-between the working periods in study I (TLT) and III 
whereas in study I (OLT) and II the subjects switched between the two legs, allowing one leg 
to rest while the other was working.   
        (a)     (b) 
Fig. 2 Aerobic high intensity interval training performed by treadmill walking while breathing 
supplemental oxygen (a) and one and two legs cycling while breathing ambient air (b). 
Training intensity was chosen after documentation of the superiority of the aerobic high 
intensity training compared to moderate intensity training in healthy individuals and patients 
[119-122] and calculated as % of peak heart rate, peak work load and VO2peak obtained at the 
pre training test [208]. Heart rate together with the Borg rating scale for perceived exhaustion 
was used to control the intensity during each training session. The training load was increased 
whenever the heart rate or the Borg rating score decreased under the desired level during the 
intervals. The use of heart rate as a predictor to set the training intensity in COPD patients has 
been found reliable together with the use of dyspnoea ratings [75, 209-212]. All training 
sessions were supervised by an exercise physiologist to ensure training quality and performed 
in immediate nearness to the Hospital and a pulmonary doctor to ensure safety. 
3.4 Quality of life 
Quality of life was measured by the short form 36 questionnaire (SF-36), consisting of 
questions concerning self-percepted physical and mental health status. The SF-36 
questionnaire is a multi-purpose short-form health survey, which measures medical status and 
outcome after interventions and is a generic measure, as opposed to one that targets a specific 
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age, disease, or treatment group. It has been found valid to use on COPD patients [213, 214] 
and has proven useful in surveys of general and specific populations, comparing the relative 
burden of diseases, and in differentiating the health benefits produced by a wide range of 
different treatments. Patients filled in identical questionnaires pre and post the intervention. 
3.5 Statistical analysis 
Statistical analyses were performed using the software SPSS, version 11-13 (Statistical 
Package for Social Science, Chicago, USA). Table values are expressed as mean ± standard 
deviation (SD) and as mean (range), while figure values are expressed as mean percentage 
change and data variability as standard deviation (SD) or standard error (SE). A two-tailed p 
value < 0.05 was accepted as statistically significant for all tests. Due to relatively small 
sample size in all studies, non parametric statistics were chosen for the analyses. Between 
groups differences was tested using the Mann-Whitney U test on delta values from pre to post 
test while within group changes from pre to post test and differences between normoxia and 
hyperoxia was tested using the Wilcoxon signed-rank test. 
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4 Summary of results  
Paper I: Aerobic high intensity one and two legs interval cycling in Chronic Obstructive 
Pulmonary Disease; the sum of the parts is greater than the whole 
1. Whole body VO2peak and peak work load increased by 12 and 23% in the one leg 
training group (OLT) and by 6 and 12% in the two legs training group (TLT) from pre 
to post training respectively.
2. The increase in whole body VO2peak and peak work load pre to post training was 
significantly greater in the OLT than the TLT. 
3. One leg VO2peak and peak work load increased by 18 and 37% from pre to post 
training in the OLT. 
Paper II: Aerobic high intensity one leg interval cycling improves peak oxygen uptake in 
Chronic Obstructive Pulmonary Disease patients; no additional effect from hyperoxia 
1. One leg VO2peak increased in the Hyperoxia training group (HTG) and the Normoxia 
training group (NTG) by 24 and 15% respectively whereas peak work load increased 
by 31 and 36% in the two groups respectively, from pre to post training, with no 
differences between groups. 
2. Whole body VO2peak increased in the HTG and the NTG from the one leg training by 
14 % whereas peak work load increased by 20 and 22% in the two groups 
respectively, from pre to post training, with no differences between groups. 
3. No significant difference in VO2peak between normoxia and acute hyperoxia at pre or 
post test in the HTG were found even though arterial oxygen saturation was 
significantly higher in hyperoxia at all occasions, pre and post one and two legs, by 5, 
5, 4 and 6% respectively. 
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Paper III: Hyperoxic interval training in chronic obstructive pulmonary disease patients 
with oxygen desaturation at peak exercise
1. VO2peak and peak work load increased by 19 and 75% respectively in the COPD group 
and by 15 and 30% respectively in the CAD group from pre to post training. 
2. In the COPD group, VO2peak and peak work load was significantly higher in acute 
hyperoxia compared to normoxia at pre test by 20 and 32% respectively and at post 
test by 14 and 26% respectively. 
3. Arterial oxygen saturation was significantly higher (13%) in hyperoxia compared to 
normoxia at pre and post test.  
4. Work economy was 10% improved in the COPD and CAD group form pre to post 
training.
5. Quality of life was improved in the COPD group in both self-percepted physical and 
mental health status by 24 and 35 % respectively. 
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5 Discussion
The present thesis demonstrates that aerobic high intensity interval training at 85-95% of peak 
heart rate increases VO2peak and peak work load in patients with severe COPD in different 
types of exercises such as regularly cycling (I), one leg cycling (I, II) and treadmill walking 
(III). Hyperoxic training is an advantage in whole body work in patients with hypoxemia 
(SpO2 < 88%) during exercise. The one leg cycling training was superior to the two legs 
cycling training (I). One leg cycling was more efficient when measured as % improvement 
pre to post training compared to two legs cycling in normoxia and hyperoxia (II), and 
treadmill walking in hyperoxia (III). Patients without hypoxemia during exercise (I-II) were 
mainly demand limited by the skeletal muscles capacity to consume oxygen before and after 
the training intervention. Hyperoxic patients during exercise (III) were limited by the capacity 
to supply oxygen to the skeletal muscles in both the untrained and trained state.
5.1 Increase in peak oxygen uptake
5.1.1 Training using reduced muscle mass vs. whole body work
5.1.1.1 Central and peripheral stimuli 
In the present thesis, one leg cycling (I, II) increased whole body VO2peak by 12-14% which 
were significantly more than two legs cycling with an increase of 6% pre to post training (I). 
This demonstrates the importance of a high intensity performance at the muscular level during 
training. It has been demonstrated that COPD patients are able to perform almost four times 
more work during one leg exercise compared to two legs exercise, and lower ventilation 
allows the patients to exercise longer at the same muscle specific intensity [160]. One leg 
cycling allows the patients to train at a higher muscle specific intensity compared to whole 
body exercise as the ventilatory load is relatively reduced and skeletal muscle blood flow is 
increased [166], thereby greater training responses is revealed. The present findings from the 
one leg training (I, II) is supported by a recent study of COPD patients [128]. After 7 weeks 
of high intensity training, cycling with each of both legs at 50% of two legs peak work load 
for 15 min increased VO2peak in the one leg cycling group by 20%. However no significant 
change in VO2peak in the two legs group which trained continuous cycling for 30 min at 70% 
of peak work load was found. These results indicate that one leg cycling enhances the 
adaptive response of peripheral muscle more than conventional two legs cycling.
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In the present thesis, VO2peak and peak work load were significantly increased both in one and 
two leg cycling after one leg training (I). However one leg VO2peak increased more than whole 
body VO2peak after one leg cycling, which indicates a central limitation to whole body work in 
these COPD patients. The ability to consume oxygen by the peripheral muscle before the 
training intervention was stressed to the limit during one leg cycling, and since the work 
performed one by one leg was greater than when working together, the patients had a 
peripheral muscle reserve capacity when performing two legs cycling. These findings 
appeared even clearer after the training intervention as the difference between one and two 
legs VO2peak were smaller which indicate that the peripheral muscle capacity was relatively 
more improved than the central factors. One leg VO2peak was about 60 % of two legs VO2peak
at pre test whereas at post test the one leg VO2peak was about 80 % of two legs VO2peak which 
suggests an increase mainly attributed to the peripheral muscle level. The less improved 
VO2peak in two legs cycling might be explained by that locally improved aerobic endurance 
training, here represented by one leg cycling, might be of less advantage in exercise with large 
muscle mass if the central circulation is not equally improved. This is in line with others who 
have demonstrated reduced whole body VO2peak compared to one leg VO2peak after training 
each leg separately [45, 161, 167]. Training with one leg in healthy people has been 
demonstrated not to represent a sufficient stimulation of the central circulation to produce an 
improvement of cardiac function as it is emphasized that large muscle groups must be 
engaged to induce central circulation [215]. Peak heart rate was unaffected by training (I,II), 
similar to the study by Klausen et al. [161] and was during peak one leg cycling about 90% of 
peak two legs cycling, thereby the cardiovascular system was not maximally challenged 
during the one leg cycling and the training was well tolerated by the patients. However as the 
peak heart rate during two legs cycling did not differ between pre and post test with a 
significantly greater VO2peak and peak work load, a certain central training adaptation most 
likely occurred after the one leg training (I, II). The findings in study I indicated a central 
limitation in the ability to supply the working muscles adequately with oxygen when attending 
whole body exercise. This is in accordance with findings of Richardson et al. [40] who 
compared single leg knee extensor exercise with stationary two legs cycling and found that 
patients with COPD were able to exercise at a higher muscle specific intensity during single 
leg extensor exercise compared to conventional cycling. Their findings indicated a metabolic 
reserve in the exercising muscle when the patient terminared two legs exercise. Training with 
reduced muscle mass has given evidence in favour of an increased portion of cardiac output to 
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the working muscles, because the capacity of the cardiovascular system is not taxed 
maximally, both in healthy and in COPD patients [40, 43]. Thereby a relatively greater 
training adaptation might have occurred in the peripheral muscles compared to the central 
factors leading to an imbalance which might result in a peripheral reserve capacity during 
whole body work in COPD patients.
Similar to the findings in study I, study II demonstrated a reduced training response in whole 
body VO2peak compared to one leg VO2peak. Thereby we attend towards the “peripheral muscle 
reserve capacity during whole body work” theory as in study I. However, in study II it was 
also demonstrated that acute hyperoxia did not increase VO2peak above the level found in 
normoxia during whole body work, even though arterial oxygen saturation per see was 
increased. This finding indicated an oxygen demand limitation in the peripheral muscles to 
utilize the increased arterial oxygen saturation. Even though arterial oxygen content is 
increased, we do not know if the oxygen content in the peripheral vessels is equally increased 
or if the oxygen cascade from the arteries to the periphery is significantly decreased. Central 
factors such as the respiratory work, cardiac output and blood flow might limit the 
performance in whole body work compared to one leg work which might also count for an 
central limitation to supply the peripheral muscles with oxygenated blood [38]. As the 
ventilation is equally high during peak one and two legs cycling, a reasonable explanation for 
the reduced increase in whole body work compared to one leg is a ventilatory limitation to 
perform whole body work in patients with COPD due to a ventilatory ceiling which results in 
a termination of work before the peak capacity is reached in the peripheral muscles. If that is 
the case, increased oxygen content in the periphery would not be of any importance.  
5.1.1.2 Ventilation 
The ventilation/VO2 relationship were constant and independent of the muscle mass involved 
during testing (I, II). However, as the VO2peak during one leg cycling were significantly lower 
than the VO2peak during two legs cycling, one leg cycling requires lower ventilation than two 
legs cycling at the same relative work load. Thereby, if there is a ventilatory ceiling when 
concerning high intensity training in COPD patients, training with a reduced muscle mass 
allows for a higher relative work load compared with whole body work. As illustrated in 
figure 1 in paper I, a significantly lower training work load in the one leg group compared to 
the two legs group was found during the first two weeks of the training intervention. 
However, from week 3, the work load was not different between the groups in which the one 
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leg group trained at the same work load as the two legs group, by cycling with each of both 
legs separately. During the last week of training, the one and two legs group actually trained 
at the exactly same work load by cycling with one leg at a time and two legs together 
respectively. The reduced pulmonary function of patients suffering from COPD indirectly 
influences the intensity and thus training stimulus negatively due to the heavy work of 
breathing and dyspnoea during whole body aerobic high intensity interval training. It is 
suggested  that in COPD patients, blood flow directed to the peripheral muscles and oxygen 
extraction may be limited due to a redistribution of cardiac output and oxygen from the 
peripheral working muscles to the ventilatory muscles [38]. This is demonstrated by the 
greater increase in VO2peak after the one leg cycling training period when the lungs are less 
challenged at the same relative muscle specific intensity (I, II). As demonstrated in the study 
by Harms et al. [166], respiratory work during maximal exercise caused changes in locomotor 
muscular resistance and perfusion, and thereby directly changed VO2 in the leg. In addition 
these changes were greatest when the ventilatory work was increased. A redistribution of 
cardiac output from the locomotor muscles to the ventilatory muscles limits blood flow and 
oxygen extraction during whole body work [38]. Thereby as training with an isolated muscle 
mass relatively reduces the work of breathing, oxygenated blood is directed to the working 
skeletal muscles. This will allow the patients to work at a higher muscle specific work load 
before they reach the ventilation limitation. As demonstrated in study I and II the peak work 
load performed by one leg alone was about 60 and 80% of the sum of the two legs work load 
together at pre and post test respectively, giving a greater peripheral muscle stimulus during 
one leg training. These findings are in line with the study by Dolmage et al. [160] who 
demonstrated that the COPD patients during single leg exercise were able to perform 80% of 
the power output performed during two legs cycling suggesting that the exercising muscle 
was not maximally stressed during two legs exercise. Reduced ventilation has been reported 
to increase blood flow [163, 166] and thereby more oxygenated blood might have been 
distributed to the mitochondria available for energy transfer. It has been demonstrated that 
after a training period, leg blood flow increases during one leg exercise, but decreases during 
two legs exercise [161]. As more blood is distributed to an isolated area during the one leg 
work, it induces shear stress to the vessels. To alleviate this increased shear stress structural 
changes occurs [216]. Since leg vascular resistance decreases during one leg exercise, VO2peak
per unit tissue depends on the muscle mass involved [161]. A vascular constriction during two 
legs cycling could have attributed to the reduced training stimulus (I) and to the small 
difference between one and two legs VO2peak and peak work load (I, II). It has been 
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demonstrated that involving a larger muscle mass into the work induces vasoconstriction in 
the periphery and subsequently reduces leg VO2peak and blood flow to the peripheral muscles 
[162, 217-219].
5.1.2 Training responses in normoxia vs.  hyperoxia 
In study I, the one leg training revealed great changes pre to post training in both one and two 
legs VO2peak by 18 and 12% respectively, and peak work load by 37 and 23% respectively. 
The increases in VO2peak and peak work load were greater from the one leg training compared 
to the two legs training which increased VO2peak and peak work load by 6 and 12% pre to post 
training respectively. This difference was found to be due to an increased peripheral stimuli 
during the one leg training, and thought be attributed to the increased blood flow and oxygen 
delivery to the peripheral skeletal muscles, and thereby the oxygen availability in the 
mitochondria. A further increase in VO2peak and peak work load by performing the exact same 
training intervention in hyperoxia was thereby hypothesised to reveal even greater training 
responses in study II due to further increased oxygen availability in the peripheral muscles. In 
all studies of the present thesis (I-III), both during one and two legs cycling, arterial oxygen 
saturation was significantly higher in hyperoxia compared to normoxia. The increased arterial 
oxygen saturation is hypothesised to increase oxygen delivery to the periphery and thus 
increase the peripheral muscle stimulus. However, aerobic high intensity interval one leg 
cycling in hyperoxia had no additional effect compared to the same training intervention in 
normoxia when concerning increased VO2peak from pre to post training (II). This finding is 
supported by others who have found no additional effect of hyperoxia during training, 
however one of the studies did not find any increase in VO2peak either by breathing ambient air 
or supplemental oxygen [129] and the other study did not measure VO2peak [195]. Both studies 
consisted of whole body exercise. Several factors might explain lack of improvement in 
VO2peak in hyperoxia compared to normoxia in study II. Hyperoxia was adopted to increase 
the oxygen content and thereby oxygen pressure in the capillaries leading to an increased 
energy transfer and power output at the muscular level. Arterial oxygen saturation was 
significantly increased in hyperoxia compared to normoxia in the COPD patients in both the 
hyperoxic studies (II-III). In spite of these differences, similar improvements in VO2peak by 
training one leg cycling in normoxia and hyperoxia in study II was found. A plausible 
explanation could be that during one leg cycling training the ventilatory system was relatively 
less stressed, thereby the blood was already distributed to the periphery. Due to the reduced 
muscle mass, the continuously presence of a greater blood flow with oxygenated blood in the 
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working skeletal muscles induced satisfactory stimulation on the peripheral muscles allowing 
a maximal metabolic muscular work even in normoxia. Richardson et al. [35] demonstrated 
that hypoxemia during exercise resulted in increased blood flow and a greater oxygen 
extraction in the tissues without any change in VO2. It is thereby reasonable to believe that 
blood flow is regulated by arterial oxygen content and muscle oxygen demand. One leg 
cycling did not induce oxygen desaturation at peak exercise, thereby it is reasonable to 
anticipate a satisfactorily maintained oxygen saturation during the training sessions in 
normoxia as well (I, II).   
As demonstrated in study II, non hypoxemic COPD patients significantly decreased 
ventilation by 12% and increased work load by 13% during peak two legs cycling in 
hyperoxia compared to normoxia both pre and post training. This is in line with others 
demonstrating that hyperoxia might reduce ventilation and result in a higher muscular specific 
training intensity in those without hypoxemia at peak exercise [180, 182, 186-188, 195]. 
However during one leg peak cycling, ventilation and work load was not different between 
hyperoxia and normoxia. Thereby the finding that hyperoxic one leg cycling training did not 
increase VO2peak above the level attained by normoxic training after eight weeks of aerobic 
high intensity interval training is not incomprehensible. As ventilation, blood flow and 
oxygen saturation might be optimal during the one leg cycling condition, even in normoxia, 
the effect of hyperoxia in a contrary situation was investigated in study III. The response of 
hyperoxia during aerobic high intensity interval treadmill walking in patients with hypoxemia 
during peak exercise was revealed. Findings from study III demonstrated greater increase in 
VO2peak (19%) compared to studies I and II (6, 12 and 14%). In study III, a significant higher 
VO2peak and peak work load in hyperoxia compared to normoxia at pre and post test was 
found, however without any difference in ventilation. This indicate that exercise hypoxemic 
COPD patients is able to sustain a higher intensity at the same relative ventilation in 
hyperoxia compared to normoxia, resulting in great improvements in VO2peak. Several studies 
have demonstrated an improved performance and ventilation in hyperoxia compared to 
normoxia in both those with mild resting hypoxemia, hypoxemia during exercise [186, 220] 
and in those without hypoxemia during exercise [127, 180, 182, 184, 187, 221]. An important 
fact in the present thesis is that the patients in study III were the patients most afflicted by the 
disease with the lowest pulmonary functions and the lowest initial fitness status which may 
account for larger relative improvement in VO2peak [113, 215].
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As demonstrated in the present thesis (I) and by others, one leg cycling in normoxia gives a 
great opportunity to induce optimized training conditions in the peripheral muscles. This is 
due to that the respiratory muscle work is relatively reduced and the blood flow and oxygen 
saturation increased [161, 162], which induces only small differences in hyperoxia (II). In 
whole body work however, central factors such as respiratory muscle work, cardio vascular 
vasoregulation and arterial oxygen saturation influences to a greater extent the performance, 
thereby the hyperoxic responses is much more evident. This is evidenced by larger 
improvements in VO2peak after hyperoxic treadmill walking (III) (19%) than after normoxic 
two legs cycling (I) (6%). It is also evidenced by increased VO2peak in hyperoxia compared to 
normoxia (III). Thereby it is not surprising that whole body exercise in study I and III 
demonstrated the most different results when concerning the physiological training effects 
from pre to post training. Patients who walked at the treadmill, oxygen desaturated at the 
training intensity level and had their arterial oxygen saturation restored in hyperoxia. The two 
legs cycling group also had reduced arterial oxygen saturation during training, however they 
were not hypoxemic (SpO2 < 88%). As the treadmill hyperoxic training group demonstrated 
19% increased VO2peak compared to the 6% in the cycling normoxic training group, possible 
parameters other than oxygen availability in the muscle might have contributed to limit the 
performance in the whole body work. It seems from the one leg interventions (I, II) that a 
ventilation ceiling might contribute to exercise limitation before the skeletal muscle reaches 
its limitation during whole body work. Thus the relatively reduced ventilation induced by 
breathing oxygen in study III might have redistributed blood to the locomotor muscles which 
allowed the treadmill group to train at a higher peripheral skeletal muscle specific intensity 
than the two legs cycling group in study I. Thereby the treadmill group might have increased 
the training intensity at a faster rate than the normoxic group. This assumption is supported by 
the findings of others [127, 195] demonstrating that during training in hyperoxia, intensity 
could be kept at a higher level resulting in improved endurance capacity and breathing pattern 
compared to normoxia. Even though the two legs cycling group (I) were not hyperoxic, a 
reduction in arterial oxygen content at peak exercise was present and might have been 
determining as the blood flow is decreased in whole body work and thereby the oxygen 
availability might be reduced. 
5.1.3 Stationary cycling vs. treadmill walking 
When comparing percent increase in whole body VO2peak from pre to post training in studies 
I-III, treadmill walking in hyperoxia (III) had the greatest improvement in VO2peak which was 
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three times the improvement found after the two legs cycling (I), by 19 and 6% respectively. 
One leg cycling (I-II) came next to the hyperoxic treadmill exercise with an increase in whole 
body peak exercise of 12 and 14% respectively, while two legs cycling (I) increased the least 
after performing the same training intervention, aerobic high intensity interval training. Even 
though inclined treadmill workout has been found to induce 10-20% better performance 
during walking and running compared to stationary biking [32], the subjects trained and tested 
at the same physical device pre and post training and should therefore not be affected by these 
differences. Ergometer cycling was chosen as intervention to compare reduced muscle mass 
training with whole body training (i.e. one and two legs cycling). Treadmill walking was 
chosen in study III as the aim was to investigate the hyperoxic response in a condition where 
normoxia probably would limit exercise and maximally challenge the oxygen 
delivery/availability issue. During treadmill walking, a greater muscle mass is required and 
reveals greater ventilatory requirements compared to stationary cycling [222, 223]. As 
treadmill walking induces performance to a greater extent than cycling [32], the greater 
increase in VO2peak from the treadmill study (III) might be explained by a greater training 
adaptation in the cardiovascular system in addition to the peripheral skeletal muscles, than 
seen in the cycling studies (I, II).  
5.2 Limitations to VO2peak 
Hyperoxia significantly increased arterial oxygen saturation compared to normoxia at peak 
exercise in both one and two legs cycling at pre and post test in the COPD patients (II, III) by 
4-13%. The greatest increase was found in study III by a 13%, not surprisingly as these 
patients were hypoxemic at peak exercise in normoxia. Increased arterial oxygen saturation 
demonstrates improved oxygen availability in the arteries during activity. The results from the 
present studies (I-III) lay the foundation for further investigation into the mechanisms behind 
the oxygen content in the peripheral vascular bed and blood flow in COPD patients as these 
parameters was not measured in the present thesis. In a study by Maltais et al. [39] greater leg 
blood flow and oxygen uptake in hyperoxia compared to normoxia was demonstrated in 14 
COPD patients, however these results were calculated and not directly measured.  
We might speculate that the oxygen availability and thus oxygen pressure was increased in 
the mitochondria in the patients of the present studies. If so, the patients in study II were 
exercise limited by the muscles to utilize the increased available oxygen in acute hyperoxia, 
demonstrated by no further increase in VO2peak compared to normoxia pre or post training. 
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This suggest a limitation in the peripheral working muscles to consume the available oxygen 
with no reserve capacity during whole body work both before and after the training period, 
indicating an excess of mitochondrial capacity [192]. As two legs VO2peak increased less than 
one leg VO2peak from pre to post training in study I, it was concluded that the patients had a 
peripheral muscle reserve capacity when concerning whole body VO2peak after the training 
period when the peripheral muscles had gained training adaptations exceeding the central 
limitations to supply the working muscles with oxygen. The difference between whole body 
VO2peak and one leg VO2peak was reduced after the training supporting the assumption that the 
peripheral training adaption far exceeds the cardiovascular adaptations. The speculations from 
study I was partly supported by the findings from study II as it was demonstrated that whole 
body VO2peak increased less than one leg cycling indicating a reserve capacity in the 
peripheral muscles during two legs cycling. However, the assumption that the main limitation 
was oxygen availability became weakened as acute hyperoxia with concomitant increased 
arterial oxygen saturation did not increase VO2peak compared to normoxia. This demonstrates 
that the reduced peak whole body capacity compared to one leg work might not have been an 
oxygen saturation limitation. It might rather be a ventilation and/or oxygen delivery limitation 
through decreased blood flow or diffusion limitation, resulting in the peripheral skeletal 
muscle reserve capacity during whole body performance. In study III, acute administration of 
hyperoxia resulted in increased VO2peak compared to normoxia both before and after the 
training intervention in the normoxic peak exercise hypoxemic COPD patients, indicating a 
supply limitation to deliver oxygen to the periphery by the cardiopulmonary system during 
normoxic conditions. This is supported by the findings that hyperoxia improves muscle 
electrical activity during dynamic exercise and that the hypoxemia-induced skeletal muscle 
dysfunction most probably acts through mechanisms based on oxygen availability [191]. The 
findings concerning the difference in normoxic and hyperoxic response on VO2peak between 
study II and III might be due to the great difference in arterial oxygen saturation in study III 
between normoxia and hyperoxia, which were 13% higher in hyperoxia at pre and post test. 
Severe COPD patients with hypoxemia at peak exercise thereby seems to have the same 
exercise limitations as highly trained endurance athletes as it is stated that exercise training 
appears to result in a switch from metabolic demand limitation to oxygen supply limitation of 
peak exercise [31]. 
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5.3 Work economy  
Submaximal VO2 at a standard work load was reduced by 10% after 8 weeks of aerobic high 
intensity interval treadmill walking in the COPD and CAD patients (III). Thereby the patients 
were able to perform 5 minutes of treadmill walking at 20 and 40 watts respectively with a 
significantly lower oxygen demand post training compared to pre training. Increased strength 
and VO2peak in COPD might slow the reliance upon type II muscle fibres as exercise intensity 
increases and lead to an improved muscular work [49, 112]. To be able to perform daily 
activities and maintain a satisfactory quality of life, an improved work economy might be 
crucial in COPD patients as their exercise capacity is extremely poor [1]. Maximal strength 
training improves mechanical efficiency, rate of force development and pulmonary function 
in COPD patients by 32, 105 and 22% respectively, pre to post 8 weeks of training [100]. This 
might be translated into either having the potential to perform significantly more work, or to 
perform the same work with a reduced effort without an increased VO2peak. A training 
intervention consisting of both aerobic high intensity interval training and maximal strength 
training would thus be beneficial for further improvement in work economy.  
5.4 Quality of life 
An improved measure outcome of the SF-36 health related quality of life questionnaire was 
detected after 8 weeks of aerobic high intensity interval treadmill walking in the COPD 
patients (III). Both physical and psychical states had improved pre to post training by 24 and 
35% respectively. The patients improved VO2peak and work economy pre to post training by 
19 and 10% respectively. These improvements most likely had influenced daily living to a 
great extent resulting in an improved self percepted quality of life questionnaire outcome. As 
the modality of training was walking, the great improvements in quality of life score can be 
explained by the fact that walking is the kind of exercise mostly involved in the patient’s 
usual activities, and the improved exercise capacity is thereby well experienced throughout 
the subject’s daily routine. Increased quality of life has also been demonstrated by others after 
strength and endurance training interventions [100, 126, 202, 224] and is an important aspect 
when including endurance training into clinical practice for COPD patients. 
5.5 Limitations 
A challenge during the work of the present thesis was to recruit COPD patients willing to 
participate in a training intervention. A low number of participants might be looked upon as a 
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weakness of the studies as minor differences might not be significant. However, even with a 
small number of subjects in the groups, significant differences was demonstrated and thereby 
strengthens the results. A longer training period than in the present studies might also have 
increased VO2peak to a even greater extent than what was found after eight weeks. 
5.6 Perspectives
COPD is one of the most rapid increasing diseases that world-wide is afflicting millions of 
people. It is important to reveal strategies to prevent morbidity and mortality in these patients 
in an effective manner both to improve quality of life for the patients and due to the economic 
burdens of the society. As the disease itself is not fully reversible, rehabilitation has to focus 
on how to gain optimal physiological adaptations and mobility in spite of the disease. In 
theory, exercise is well accepted as a part of any rehabilitation program, however until now 
there has not been a clear recommendation of training modality. There is a strong correlation 
between endurance capacity expressed as VO2max and the risk for mortality, morbidity and 
immobility. Whereas most COPD patients demonstrates low VO2peak that declines over time, 
exercise strategies which emphasise effective improvement in VO2peak should be in focus.
The present studies demonstrates that intensity is the most important factor to improve 
VO2peak in COPD patients. An overall conclusion is that due to the pulmonary disease, 
interventions that maximally challenge working muscle oxidation and taxes ventilation to a 
lesser degree, is the main factor in improving VO2peak. Training with a reduced muscle mass 
was found to be effective in severe COPD patients as ventilation was relatively reduced and 
thereby the muscular work increased. In severe COPD patients with hypoxemia during 
exercise, hyperoxia increases arterial oxygen saturation and allows for a greater training 
intensity at the same ventilatory load. The findings from the present thesis adds important 
information on improvements in exercise capacity in COPD patients. One leg training, as well 
as hyperoxia for patients with hypoxemia during exercise, should be implemented as a main 
strategy in future clinical practice. Understanding and communicating new developments in 
physiological research is the least of the problems in terms of changing existing rehabilitation 
practises. The challenge is to ensure that this information is acted upon by medical doctors 
and patients. 
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6 Conclusions
Aerobic high intensity interval one and two legs cycling at 85-95% of peak heart rate 
significantly increased whole body VO2peak and work load pre to post training. A significantly 
greater increase after one leg cycling compared to two legs cycling was found. The work load 
performed leg by leg is greater than when working together, however the ventilatory load is 
not different. Thereby the relative ventilation is reduced during the one leg cycling which 
allows the patients to train at a higher muscle-specific intensity compared to whole body 
exercise resulting in a significantly greater training response. These results indicate a demand 
rather than a central limitation to VO2peak in these COPD patients. 
Aerobic high intensity one leg interval cycling at 85-95% of peak heart rate in hyperoxia and 
normoxia significantly increased VO2peak and work load in both one and two legs cycling with 
no additional training effect in hyperoxia compared to normoxia. Increased arterial oxygen 
saturation per se. in acute hyperoxia at pre and post test failed to increase VO2peak above the 
level attained in normoxia even though peak work load were significantly higher, indicating a
demand limitation to consume oxygen in the peripheral muscles.  
Hyperoxic aerobic high intensity interval training at 85-95% of peak heart rate in COPD 
patients with hypoxemia at peak exercise improved VO2peak, peak work load, work economy 
and quality of life pre to post training. Acute hyperoxia increased VO2peak and peak work load 
significantly more at pre and post test compared to normoxia in the COPD patients. This 
indicates an oxygen supply limitation to VO2peak in normoxia, whereas no difference between 
acute hyperoxia and normoxia suggesting oxygen demand limitation in the CAD patients. 
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